Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Durham

Showing results (291-300 of 477) with videos related to

Pageof 48
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 23, 2009
Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ populationA E Anderson, K J Mackerness, M Aizen, et al.
The Laryngoscope|September 19, 2024
JAK-inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case ReportMeryem Demir, Vasileios Kouranos, Kostadin Stoenchev, et al.
European Journal of Immunology|January 1, 1996
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES proteinS Ying, Q Meng, L Taborda-Barata, et al.
The New England Journal of Medicine|January 30, 1992
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthmaD S Robinson, Q Hamid, S Ying, et al.
Allergy|October 27, 1998
Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthmaG Menz, S Ying, S R Durham, et al.
Immunology|June 1, 1994
Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitisK Masuyama, M R Jacobson, S Rak, et al.
Allergy|May 18, 2016
Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic reviewH H Tam, M A Calderon, L Manikam, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Reduced T-bet in addition to enhanced STAT6 and GATA3 expressing T cells contribute to human allergen-induced late responsesA O Eifan, K Furukido, A Dumitru, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 1, 1994
Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challengeS Rak, M R Jacobson, R M Sudderick, et al.
Allergy|January 1, 1985
Mediators of hypersensitivity and "fog"-induced asthmaR J Shaw, S D Anderson, S R Durham, et al.
Pageof 48

Showing results (291-300 of 477) with videos related to

Sort By:
Pageof 48
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 23, 2009
Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ populationA E Anderson, K J Mackerness, M Aizen, et al.
The Laryngoscope|September 19, 2024
JAK-inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case ReportMeryem Demir, Vasileios Kouranos, Kostadin Stoenchev, et al.
European Journal of Immunology|January 1, 1996
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES proteinS Ying, Q Meng, L Taborda-Barata, et al.
The New England Journal of Medicine|January 30, 1992
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthmaD S Robinson, Q Hamid, S Ying, et al.
Allergy|October 27, 1998
Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthmaG Menz, S Ying, S R Durham, et al.
Immunology|June 1, 1994
Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitisK Masuyama, M R Jacobson, S Rak, et al.
Allergy|May 18, 2016
Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic reviewH H Tam, M A Calderon, L Manikam, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Reduced T-bet in addition to enhanced STAT6 and GATA3 expressing T cells contribute to human allergen-induced late responsesA O Eifan, K Furukido, A Dumitru, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 1, 1994
Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challengeS Rak, M R Jacobson, R M Sudderick, et al.
Allergy|January 1, 1985
Mediators of hypersensitivity and "fog"-induced asthmaR J Shaw, S D Anderson, S R Durham, et al.
Pageof 48